Login to Your Account

CV Therapeutics Gets FDA OK To Sell Ranexa In Angina

By Aaron Lorenzo

Tuesday, January 31, 2006
At last, the FDA cleared Ranexa (ranolazine extended-release tablets), the first new angina drug approved in the U.S. in more than 20 years. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription